Ambu A/S (AMBBY)
USD 14.18
(0.0%)
USD 14.18
(0.0%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 | 645 Million DKK | 113.58% |
| 2023 | 302 Million DKK | 109.72% |
| 2022 | 144 Million DKK | -57.65% |
| 2021 | 340 Million DKK | -20.56% |
| 2020 | 428 Million DKK | -14.23% |
| 2019 | 499 Million DKK | -11.37% |
| 2018 | 563 Million DKK | 25.11% |
| 2017 | 450 Million DKK | 26.4% |
| 2016 | 356 Million DKK | 50.85% |
| 2015 | 236 Million DKK | 19.19% |
| 2014 | 198 Million DKK | 98.0% |
| 2013 | 100 Million DKK | -33.63% |
| 2012 | 150.66 Million DKK | 35.33% |
| 2011 | 111.33 Million DKK | -3.88% |
| 2010 | 115.82 Million DKK | 51.69% |
| 2009 | 76.35 Million DKK | -11.62% |
| 2008 | 86.39 Million DKK | 24.76% |
| 2007 | 69.24 Million DKK | -16.24% |
| 2006 | 82.66 Million DKK | 36.42% |
| 2005 | 60.59 Million DKK | -4.31% |
| 2004 | 63.32 Million DKK | 21.08% |
| 2003 | 52.3 Million DKK | 47.16% |
| 2002 | 35.54 Million DKK | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q1 | 126 Million DKK | 29.9% |
| 2024 Q3 | 178 Million DKK | -8.25% |
| 2024 Q2 | 194 Million DKK | 53.97% |
| 2023 Q1 | 68 Million DKK | 1033.33% |
| 2023 Q4 | 97 Million DKK | 6.59% |
| 2023 Q3 | 91 Million DKK | 97.83% |
| 2023 FY | 302 Million DKK | 109.72% |
| 2023 Q2 | 46 Million DKK | -32.35% |
| 2022 Q2 | 189 Million DKK | 372.5% |
| 2022 Q1 | 40 Million DKK | 900.0% |
| 2022 Q3 | 53 Million DKK | -71.96% |
| 2022 FY | 144 Million DKK | -57.65% |
| 2022 Q4 | 6 Million DKK | -88.68% |
| 2021 Q2 | 100 Million DKK | -32.43% |
| 2021 Q3 | 88 Million DKK | -12.0% |
| 2021 Q4 | 4 Million DKK | -95.45% |
| 2021 Q1 | 148 Million DKK | 410.34% |
| 2021 FY | 340 Million DKK | -20.56% |
| 2020 Q4 | 29 Million DKK | -81.41% |
| 2020 Q2 | 150 Million DKK | 61.29% |
| 2020 FY | 428 Million DKK | -14.23% |
| 2020 Q1 | 93 Million DKK | 178.81% |
| 2020 Q3 | 156 Million DKK | 4.0% |
| 2019 Q2 | 195 Million DKK | 74.11% |
| 2019 Q1 | 112 Million DKK | -32.12% |
| 2019 FY | 499 Million DKK | -11.37% |
| 2019 Q4 | -118 Million DKK | -200.85% |
| 2019 Q3 | 117 Million DKK | -40.0% |
| 2018 Q1 | 91 Million DKK | -36.81% |
| 2018 FY | 563 Million DKK | 25.11% |
| 2018 Q2 | 156 Million DKK | 71.43% |
| 2018 Q3 | 151 Million DKK | -3.21% |
| 2018 Q4 | 165 Million DKK | 9.27% |
| 2017 Q2 | 121 Million DKK | 86.15% |
| 2017 FY | 450 Million DKK | 26.4% |
| 2017 Q4 | 144 Million DKK | 10.77% |
| 2017 Q3 | 130 Million DKK | 7.44% |
| 2017 Q1 | 65 Million DKK | -50.38% |
| 2016 Q3 | 94 Million DKK | 10.59% |
| 2016 FY | 356 Million DKK | 50.85% |
| 2016 Q4 | 131 Million DKK | 39.36% |
| 2016 Q1 | 46 Million DKK | -60.68% |
| 2016 Q2 | 85 Million DKK | 84.78% |
| 2015 Q3 | 56 Million DKK | 16.67% |
| 2015 Q4 | 117 Million DKK | 108.93% |
| 2015 FY | 236 Million DKK | 19.19% |
| 2015 Q1 | 15 Million DKK | -81.25% |
| 2015 Q2 | 48 Million DKK | 220.0% |
| 2014 Q3 | 55 Million DKK | 17.02% |
| 2014 Q4 | 80 Million DKK | 45.45% |
| 2014 Q1 | 16 Million DKK | -64.13% |
| 2014 Q2 | 47 Million DKK | 193.75% |
| 2014 FY | 198 Million DKK | 98.0% |
| 2013 Q4 | 44.6 Million DKK | 79.84% |
| 2013 FY | 100 Million DKK | -33.63% |
| 2013 Q3 | 24.8 Million DKK | 172.53% |
| 2013 Q2 | 9.1 Million DKK | -57.48% |
| 2013 Q1 | 21.4 Million DKK | -55.94% |
| 2012 Q4 | 48.56 Million DKK | 34.16% |
| 2012 Q1 | 26 Million DKK | -39.72% |
| 2012 FY | 150.66 Million DKK | 35.33% |
| 2012 Q2 | 39.9 Million DKK | 53.46% |
| 2012 Q3 | 36.2 Million DKK | -9.27% |
| 2011 Q2 | 5 Million DKK | -82.76% |
| 2011 Q1 | 29 Million DKK | -9.72% |
| 2011 Q3 | 34.2 Million DKK | 584.0% |
| 2011 Q4 | 43.13 Million DKK | 26.12% |
| 2011 FY | 111.33 Million DKK | -3.88% |
| 2010 Q1 | 18.7 Million DKK | 32.12% |
| 2010 Q4 | 32.12 Million DKK | -1.46% |
| 2010 FY | 115.82 Million DKK | 51.69% |
| 2010 Q3 | 32.6 Million DKK | 0.62% |
| 2010 Q2 | 32.4 Million DKK | 73.26% |
| 2009 Q4 | 14.15 Million DKK | -35.07% |
| 2009 FY | 76.35 Million DKK | -11.62% |
| 2009 Q1 | 15.3 Million DKK | 0.0% |
| 2009 Q3 | 21.8 Million DKK | -12.8% |
| 2009 Q2 | 25 Million DKK | 63.4% |
| 2008 FY | 86.39 Million DKK | 24.76% |
| 2007 FY | 69.24 Million DKK | -16.24% |
| 2006 FY | 82.66 Million DKK | 36.42% |
| 2005 FY | 60.59 Million DKK | -4.31% |
| 2004 FY | 63.32 Million DKK | 21.08% |
| 2003 FY | 52.3 Million DKK | 47.16% |
| 2002 FY | 35.54 Million DKK | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| AVITA Medical, Inc. | -40.4 Million USD | 1696.452% |
| Manhattan Scientifics, Inc. | -703 Thousand USD | 91849.644% |
| Össur hf. | 87.46 Million USD | -637.472% |
| QHSLab, Inc. | -240.15 Thousand USD | 268673.189% |
| Wellstar International, Inc. | -1.79 Million USD | 36039.234% |
| Össur hf. | 87.46 Million USD | -637.472% |
| CVR Medical Corp. | - USD | -Infinity% |
| Bionovate Technologies Corp | - USD | -Infinity% |
| Escalon Medical Corp. | -104.47 Thousand USD | 617466.668% |
| Aurora Spine Corporation | -446.19 Thousand USD | 144655.308% |
| BrainsWay Ltd. | -4.92 Million USD | 13191.131% |
| Lattice Biologics Ltd. | - USD | -Infinity% |
| BioElectronics Corporation | -274.29 Thousand USD | 235252.576% |
| Hamilton Thorne Ltd. | 277.99 Thousand USD | -231916.892% |
| Vivos Inc. | -2.79 Million USD | 23192.241% |
| Kelyniam Global, Inc. | -239.16 Thousand USD | 269787.163% |
| REMSleep Holdings, Inc. | -1.77 Million USD | 36506.904% |
| Zecotek Photonics Inc. | -3.65 Million USD | 17738.512% |
| Avitar, Inc. | 2.73 Million USD | -23502.071% |
| Nanomix Corporation | -8.43 Million USD | 7744.745% |
| EKF Diagnostics Holdings plc | 2.08 Million USD | -30894.714% |
| Theraclion SA | -3.48 Million USD | 18629.691% |
| Lifeline Biotechnologies, Inc. | - USD | -Infinity% |
| Positron Corporation | -1.36 Million USD | 47500.331% |
| Rafina Innovations Inc. | - USD | -Infinity% |
| Electromedical Technologies, Inc. | -2.06 Million USD | 31335.759% |
| Lombard Medical, Inc. | -29.33 Million USD | 2298.739% |
| ALR Technologies Inc. | -2.94 Million USD | 21991.731% |
| Stratec SE | 25.26 Million USD | -2452.608% |
| Vycor Medical, Inc. | 40.19 Thousand USD | -1604736.904% |
| Heart Tronics, Inc. | 14.46 Million USD | -4360.555% |
| MicroPort Scientific Corporation | -516.16 Million USD | 224.96% |
| VMS Rehab Systems, Inc. | -68.66 USD | 939411693.359% |
| NewCardio, Inc. | -9.45 Million USD | 6918.732% |
| Guided Therapeutics, Inc. | -3.45 Million USD | 18757.796% |
| Ingen Technologies, Inc. | -1.61 Million USD | 40071.667% |
| Odyssey Group International, Inc. | 14.26 Million USD | -4422.801% |
| CYduct Diagnostics, Inc. | -378.9 Thousand USD | 170326.916% |
| Wellness Center USA, Inc. | -707.02 Thousand USD | 91326.939% |
| SANUWAVE Health, Inc. | -540 Thousand USD | 119544.444% |
| IR-Med Inc. | -4.91 Million USD | 13233.781% |
| Perimeter Medical Imaging AI, Inc. | -20.72 Million USD | 3211.473% |
| Polarean Imaging plc | -12.55 Million USD | 5236.92% |
| United American Healthcare Corporation | -67 Thousand USD | 962786.567% |
| ECGI Holdings, Inc. | -407.48 Thousand USD | 158389.977% |
| Nu-Med Plus, Inc. | -120.52 Thousand USD | 535254.241% |
| Capital Group Holdings, Inc. | -634.68 Thousand USD | 101724.735% |
| ADM Tronics Unlimited, Inc. | -601.52 Thousand USD | 107328.177% |
| Medical Supply International USA, Inc. | 438.18 Thousand USD | -147099.781% |
| Urologix, Inc. | -6.93 Million USD | 9407.359% |
| Rapid Therapeutic Science Laboratories, Inc. | -1.26 Million USD | 51155.422% |
| Nexeon MedSystems Inc. | -6.26 Million USD | 10395.308% |
| SS Innovations International, Inc. | -20.66 Million USD | 3220.71% |
| Qualis Innovations, Inc. | -230.24 Thousand USD | 280241.243% |
| Smith & Nephew plc | 425 Million USD | -51.765% |
| NIOX Group Plc | 4.6 Million USD | -13921.739% |
| Fuse Medical, Inc. | 383.82 Thousand USD | -167947.522% |
| Broncus Holding Corporation | -33.22 Million USD | 2041.543% |
| Brain Scientific Inc. | -9.6 Million USD | 6812.871% |
| Pressure BioSciences, Inc. | -9.5 Million USD | 6887.075% |
| Health Logic Interactive Inc. | -60.69 Thousand USD | 1062720.472% |